NCT07708402Not yet recruiting
Healing Stigma Through Stories
Healing Stigma Through Stories: Learning From International Practices to Develop and Evaluate a Narrative Program for Individuals With Schizophrenia
Source: ClinicalTrials.gov · Last updated 16 Jul 2026
Brief summary (registry, in English)
This study is the first phase of the research project. The purpose of this phase is to develop and refine a narrative-based intervention designed to reduce self-stigma among people with schizophrenia. A small pilot study will be conducted with 24 participants recruited from halfway houses in northern Taiwan. Eligible participants will receive the intervention, which consists of four group sessions and four individual sessions, held once a week for a total of eight weeks. The program uses narrative therapy techniques to help participants explore their personal experiences and reduce self-stigma. Participants will complete a workbook during the program, and the written content will be analyzed to better understand their experiences with stigma. Any personal information will be removed to protect participants' privacy. Before and after the intervention, participants will complete questionnaires on self-stigma, depression, social functioning, well-being, hope, and recovery. Information on medication use will also be collected. Group and individual sessions will be audio-recorded for research purposes. The questionnaire data and recordings will be used to evaluate the feasibility and preliminary effects of the intervention.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- First submitted
- 7 Jul 2026
- Start date
- 1 Aug 2026
- Primary completion date
- 31 Jul 2027
- Lead sponsor
- National Yang Ming Chiao Tung University
- Diseases
- Schizophrenia
- NCT number
- NCT07708402
What you commit to
- Study type: Interventional
- Planned participants: 24
- From 1 Aug 2026 to the primary completion date, 31 Jul 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Individuals who lack the capacity to provide informed consent. Decision-making capacity will be assessed using a 10-item true/false questionnaire adapted from Okoli et al. (2018). Participants who answer fewer than 7 questions correctly will be excluded. Those who answer 7 or more questions correctly will receive an additional explanation from the research team. Only individuals who demonstrate a complete understanding of the study after this explanation will be enrolled.
- Unwilling to have the intervention sessions audio-recorded.
Who the study is looking for
- Aged 18 years or older.
- Diagnosed with schizophrenia or schizoaffective disorder.
- Clinically stable at the time of study enrollment.
- Able to communicate in Mandarin Chinese or Taiwanese.
- Able to read and write and complete study questionnaires.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.